The PREVENT-CRC project continues to make strong progress toward understanding and preventing colorectal cancer through early detection of biological changes linked to intestinal health and metabolism.
Our team has reached first phase exciting milestones:
First Dataset Analysed
The initial dataset focusing on intestinal inflammation has been successfully analysed, providing valuable insights into early immune and metabolic alterations that may precede disease development.
Algorithm for Methylation Capacity Presented in Brussels
On 24th October, our novel algorithm assessing methylation capacity was presented at an international meeting, ELMO conference in Brussels. The presentation, “Gut Dysbiosis as a Determinant of One-Carbon Metabolism Deficiency”, highlighted how disruptions in gut microbiota can influence crucial biochemical pathways linked to colorectal cancer risk.
Immune Activation Testing Ready for Community Studies
Our immune activation testing platform has been fully optimised and is now ready for deployment in the mobile research unit. This will enable on-site investigations into sub-optimal health conditions directly within the community, a vital step in translating research into public health impact.
PhD Research and Metabolomics Program Underway
A dedicated PhD student has embarked on the metabolomics component of the project, integrating biochemical profiling with microbiome and methylation data. All discussions with service providers have been concluded, paving the way to launch the community research phase.
The PREVENT-CRC team is proud to see the collaboration between researchers, clinicians, and community partners gaining pace. Together, we are building the scientific foundation for preventing colorectal cancer before it starts.
Project leaders and partners:
University of MaltaĦamrun ĦaninLearn more. Join our monthly free online seminars at:
https://investinyour.health/m
